Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sven Roth
Observed names:
S Roth,
S. Roth
Institution:
Spital Zollikerberg
Observed institutions:
University of Zurich,
Sheba Medical Center,
University Hospital Zurich,
Marien Hospital Düsseldorf,
Spital Zollikerberg,
Heinrich Heine University Düsseldorf
show all 6
ORCID:
0009-0001-6063-7447
Observed ORCID:
0009-0001-6063-7447
OpenAlex ID:
A5055038298
Towards an early warning system for monitoring of cancer patients using hybrid interactive machine learning
2024
·
Andreas Trojan
, Emanuele Laurenzi
, et al.
·
Frontiers in Digital Health
·
10
Comparison of the Real-World Reporting of Symptoms and Well-Being for the HER2-Directed Trastuzumab Biosimilar Ogivri With Registry Data for Herceptin in the Treatment of Breast Cancer: Prospective Observational Study (OGIPRO) of Electronic Patient-Reported Outcomes
2024
·
Andreas Trojan
, Sven Roth
, et al.
·
JMIR Cancer
·
5
Using Machine Learning Approaches on Dynamic Patient-Reported Outcomes to Cluster Cancer Treatment-Related Symptoms
2025
·
Nora Asper
, Hans Friedrich Witschel
, et al.
·
Current Oncology
·
3
PDF
Incidence Rates of Adverse Events (CTCAE Severity ≥3) During HER2-Directed Breast Cancer Treatment Assessing the Impact of App-Based Electronic Patient-Reported Outcomes in the Randomized Controlled PRO2 Trial
2026
·
Andreas Trojan
, Marion van Mackelenbergh
, et al.
·
Current Oncology
Abstract PO3-17-04: HER2-directed biosimilar Ogivri in the treatment of breast cancer: real world reporting of symptoms and wellbeing using electronic patient reported outcome (ePRO)
2024
·
Andreas Trojan
, Sven Roth
, et al.
·
Cancer Research
EP-1281 New aspects regarding the treatment of multicentric compared to unifocal breast cancer
2019
·
C. Matuschek
, B. Tamaskovics
, et al.
·
Radiotherapy and Oncology
Abstract P6-05-03: Evaluation of predictive markers for clinical outcome after neoadjuvant radiochemotherapy in breast cancer
2013
·
C Matuschek
, E Boelke
, et al.
·
Cancer Research
Abstract P1-14-04: Long- term outcome after neoadjuvant radiochemotherapy in locally advanced non-inflammatory breast cancer and predictive factors for a pathologic complete remission; results of a multi-variate analysis
2012
·
C Matuschek
, E Boelke
, et al.
·
Cancer Research
Cyclosporine and Methotrexate (CSA/MTX) Compared With Cyclosporine and Mycophenolate Mofetil (CSA/MMF) as GVHD Prevention Regimens in Allogeneic Stem-Cell Transplantation From Unrelated Donors; Relative Outcomes Are Dependant on Disease Status at Transplantation
2011
·
A. Shimoni
, N. Shem-Tov
, et al.
·
Transplantation and Cellular Therapy
PDF
Show more works
View as search
Works count:
9
Citation count:
18
H-index:
3
I10-index:
1
Year
Topic
Type